Edgewise Therapeutics, Inc. (EWTX)
28.35
-0.53
(-1.84%)
USD |
NASDAQ |
Mar 05, 16:00
28.35
0.00 (0.00%)
After-Hours: 20:00
Edgewise Therapeutics Free Cash Flow : -144.07M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Glaukos Corp. | -39.06M |
| Nuvalent, Inc. | -275.21M |
| Neurocrine Biosciences, Inc. | 748.70M |
| Omeros Corp. | -105.32M |
| Agios Pharmaceuticals, Inc. | -377.29M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.59M |
| Cash from Investing (Quarterly) | 49.76M |
| Cash from Financing (Quarterly) | 3.975M |
| Free Cash Flow Per Share (Quarterly) | -0.3647 |
| Free Cash Flow to Equity (Quarterly) | -38.47M |
| Free Cash Flow to Firm (Quarterly) | -38.66M |
| Free Cash Flow Yield | -4.94% |